Project Start
1993-10-16
Project End
1998-10-15
Budget Start
1995-03-16
Budget End
1995-10-15
Support Year
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Georgetown University
Department
Microbiology/Immun/Virology
Type
Schools of Dentistry
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Sood, Ramesh K; Bhadti, Vishweshwar S; Fattom, Ali I et al. (2002) Novel ring-expanded nucleoside analogs exhibit potent and selective inhibition of hepatitis B virus replication in cultured human hepatoblastoma cells. Antiviral Res 53:159-64
Chu, C K; Boudinot, F D; Peek, S F et al. (1998) Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent. Antivir Ther 3:113-21
Seley, K L; Schneller, S W; De Clercq, E et al. (1998) The importance of the 4'-hydroxyl hydrogen for the anti-trypanosomal and antiviral properties of (+)-5'-noraristeromycin and two 7-deaza analogues. Bioorg Med Chem 6:797-801
Zembower, D E; Lin, Y M; Flavin, M T et al. (1998) Robustaflavone, a potential non-nucleoside anti-hepatitis B agent. Antiviral Res 39:81-8
Hostetler, K Y; Beadle, J R; Kini, G D et al. (1997) Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro. Biochem Pharmacol 53:1815-22
Korba, B A; Xie, H; Wright, K N et al. (1996) Liver-targeted antiviral nucleosides: enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo. Hepatology 23:958-63
Korba, B E (1996) In vitro evaluation of combination therapies against hepatitis B virus replication. Antiviral Res 29:49-51
Korba, B E; Boyd, M R (1996) Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells. Antimicrob Agents Chemother 40:1282-4